×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Acadia Pharma falls after patent hearing in dispute with MSN
MSN
Acadia Pharmaceutical (NASDAQ:ACAD) dropped 14% a day after a patent hearing regaring its drug Nuplazid, which is used to treat Parkinson's disease.
6 hours ago
Insider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Insider Sells 1326 Shares of Stock
Defense World
Read Insider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Insider Sells 1326 Shares of Stock at Defense World.
10 hours ago
Acadia Pharmaceuticals CEO sells shares worth $193,573 By Investing.com
Investing.com
Stephen Davis, CEO of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), recently sold 11,427 shares of the company's common stock, generating a...
1 day ago
Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it has awarded 10 academic scholarships to eligible recipients of the first...
6 days ago
Acadia Pharmaceuticals Stock Sinks After Schizophrenia Drug Study Falls Short
Investopedia
Key Takeaways · Acadia Pharmaceuticals' drug missed endpoints for treating schizophrenia patients, news that sent Acadia shares sharply lower.
1 month ago
ACAD: Buy Alert: 3 Pharma Stocks Under $20 to Invest in Now
StockNews.com
ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD): With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20...
3 days ago
James Kihara Sells 1,326 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock
MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) insider James Kihara sold 1326 shares of the company's stock in a transaction...
2 days ago
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis Sells 11427 Shares
Defense World
Read ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis Sells 11427 Shares at Defense World.
11 hours ago
Analysts Have Made A Financial Statement On ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Yearly Report
Yahoo Finance
ACADIA Pharmaceuticals is also expected to turn profitable, with statutory earnings of US$0.62 per share. Before this earnings report, the...
2 months ago
Acadia to end Nuplazid testing after schizophrenia trial flop and years of failed expansion efforts
Fierce Pharma
Acadia Pharmaceuticals is calling it quits on future testing of Nuplazid after a string of expansion efforts have come up short.
1 month ago